These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 30710182)

  • 21. ASO Author Reflections: Rethinking Spleen Preservation in Patients with Body Pancreatic Ductal Adenocarcinoma.
    Hobeika C; Sauvanet A
    Ann Surg Oncol; 2024 Jul; 31(7):4691-4692. PubMed ID: 38649552
    [No Abstract]   [Full Text] [Related]  

  • 22. ASO Author Reflections: Re-Excision for Ductal Carcinoma In Situ: Who Is at Risk?
    Lamb LR; Bahl M
    Ann Surg Oncol; 2021 Mar; 28(3):1398-1399. PubMed ID: 32946015
    [No Abstract]   [Full Text] [Related]  

  • 23. ASO Author Reflections: Even in Pancreatic Cancer, not all N Diseases are Created Equal.
    Nizri E; Lahat G; Klausner J
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):804-805. PubMed ID: 30284129
    [No Abstract]   [Full Text] [Related]  

  • 24. ASO Author Reflections: Disparities in NCCN Guideline-Compliant Care for Patients with Early-Stage Pancreatic Adenocarcinoma at Minority-Serving Versus Non-minority-Serving Hospitals.
    Lima HA; Moazzam Z; Pawlik TM
    Ann Surg Oncol; 2023 Jul; 30(7):4373-4374. PubMed ID: 36808592
    [No Abstract]   [Full Text] [Related]  

  • 25. ASO Author Reflections: A Novel Mechanism of Anticancer Effect of Skeletal Muscle-Derived Irisin in Pancreatic Ductal Adenocarcinoma.
    Sugimoto T; Iwagami Y; Kobayashi S; Yamanaka C; Sasaki K; Yamada D; Tomimaru Y; Asaoka T; Noda T; Takahashi H; Shimizu J; Doki Y; Eguchi H
    Ann Surg Oncol; 2024 Aug; 31(8):5000-5001. PubMed ID: 38722421
    [No Abstract]   [Full Text] [Related]  

  • 26. ASO Author Reflections: Progression after Resection of Noninvasive or Microinvasive Intraductal Papillary Mucinous Neoplasms.
    Al Efishat M; Allen PJ
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):822-823. PubMed ID: 30324467
    [No Abstract]   [Full Text] [Related]  

  • 27. ASO Author Reflections: Long-Term Outcomes After Surgical Resection of Pancreatic Metastases from Renal Clear-Cell Carcinoma.
    Malleo G; Salvia R; Allen PJ; Butturini G
    Ann Surg Oncol; 2021 Jun; 28(6):3109-3110. PubMed ID: 33560488
    [No Abstract]   [Full Text] [Related]  

  • 28. ASO Author Reflections: A Standard Set of Value-Based Patient-Centered Outcomes for Pancreatic Carcinoma: An International Delphi Survey.
    Pessaux P; Cherkaoui Z
    Ann Surg Oncol; 2020 Dec; 27(Suppl 3):773-774. PubMed ID: 32495283
    [No Abstract]   [Full Text] [Related]  

  • 29. ASO Author Reflections: Frailty in Pancreatic Cancers.
    Zhang F; Yan Y; Ge C
    Ann Surg Oncol; 2024 Jan; 31(1):545. PubMed ID: 37843665
    [No Abstract]   [Full Text] [Related]  

  • 30. ASO Author Reflections: Regulation of Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma by Vitamin D Supplementation.
    Mukai Y; Eguchi H
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):816-817. PubMed ID: 30324470
    [No Abstract]   [Full Text] [Related]  

  • 31. ASO Author Reflections: Unlocking the Value of Inpatient Palliative Care for Patients with Pancreatic Cancer.
    Kim S; Chervu N; Premji A; Mallick S; Verma A; Ali K; Benharash P; Donahue T
    Ann Surg Oncol; 2024 Feb; 31(2):1362-1363. PubMed ID: 38063981
    [No Abstract]   [Full Text] [Related]  

  • 32. Tumor-Infiltrating Platelets Predict Postsurgical Survival in Patients with Pancreatic Ductal Adenocarcinoma.
    Zhang SR; Yao L; Wang WQ; Xu JZ; Xu HX; Jin W; Gao HL; Wu CT; Qi ZH; Li H; Li S; Ni QX; Yu XJ; Fu DL; Liu L
    Ann Surg Oncol; 2018 Dec; 25(13):3984-3993. PubMed ID: 30171511
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ASO Author Reflections: Low Genetic Testing Utilization Among Patients with Breast, Ovarian, Pancreatic, and Prostate Cancers.
    Clark NM; Flanagan MR
    Ann Surg Oncol; 2023 Mar; 30(3):1327-1328. PubMed ID: 36322272
    [No Abstract]   [Full Text] [Related]  

  • 34. ASO Author Reflections: Pancreatic Resection Margins-Chasing Moons.
    Shah MM; Datta J; Merchant NB; Kooby DA
    Ann Surg Oncol; 2022 Mar; 29(3):1551-1552. PubMed ID: 34997421
    [No Abstract]   [Full Text] [Related]  

  • 35. ASO Author Reflections: Natural Language Processing Aids in the Detection of Incidental Pancreatic Lesions in Cross-Sectional Imaging.
    Kooragayala K; Lou J; Hong YK
    Ann Surg Oncol; 2022 Dec; 29(13):8520-8521. PubMed ID: 35969301
    [No Abstract]   [Full Text] [Related]  

  • 36. Infiltrating immune cells and gene mutations in pancreatic ductal adenocarcinoma.
    Wang WQ; Liu L; Xu HX; Wu CT; Xiang JF; Xu J; Liu C; Long J; Ni QX; Yu XJ
    Br J Surg; 2016 Aug; 103(9):1189-99. PubMed ID: 27256393
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genome-Wide Analysis Identified a Number of Dysregulated Long Noncoding RNA (lncRNA) in Human Pancreatic Ductal Adenocarcinoma.
    Hao S; Yao L; Huang J; He H; Yang F; Di Y; Jin C; Fu D
    Technol Cancer Res Treat; 2018 Jan; 17():1533034617748429. PubMed ID: 29343207
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Higher notch expression implies poor survival in pancreatic ductal adenocarcinoma: A systematic review and meta-analysis.
    Ye J; Wen J; Ning Y; Li Y
    Pancreatology; 2018 Dec; 18(8):954-961. PubMed ID: 30297095
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liquid biopsy in pancreatic ductal adenocarcinoma: current status of circulating tumor cells and circulating tumor DNA.
    Lee JS; Park SS; Lee YK; Norton JA; Jeffrey SS
    Mol Oncol; 2019 Aug; 13(8):1623-1650. PubMed ID: 31243883
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-132 Plays an Independent Prognostic Role in Pancreatic Ductal Adenocarcinoma and Acts as a Tumor Suppressor.
    Chen Y; Zhu H; Wang Y; Song Y; Zhang P; Wang Z; Gao J; Li Z; Du Y
    Technol Cancer Res Treat; 2019 Jan; 18():1533033818824314. PubMed ID: 30803373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.